Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1

Complete genome sequence of the multidrug-resistant clinical isolate Mycobacterium tuberculosis SCAID 187.0 containing several drug-resistance mutations is presented. This strain is used in experiments to study genomic and population changes leading to reversion of susceptibility to the 1st line ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilin, Aleksandr I., Kulmanov, Murat E., Korotetskiy, Ilya S., Akhmetova, Gulshara K., Lankina, Marina V., Shvidko, Sergey V., Reva, Oleg N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2015
Materias:
Prokaryotes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645197/
https://www.ncbi.nlm.nih.gov/pubmed/26543112
http://dx.doi.org/10.1128/genomeA.01272-15
Descripción
Sumario:Complete genome sequence of the multidrug-resistant clinical isolate Mycobacterium tuberculosis SCAID 187.0 containing several drug-resistance mutations is presented. This strain is used in experiments to study genomic and population changes leading to reversion of susceptibility to the 1st line anti-tuberculosis (TB) drugs under the influence of a new medicinal drug FS-1.

Ejemplares similares